Oncology News | pharmaphorum

News

J&J throws the gauntlet down to AZ with new survival data

New survival data from MARIPOSA for Johnson & Johnson's Rybrevant/Lazcluze combination in lung cancer could spell trouble for AstraZeneca.

News

Character Bio chief executive and co-founder Cheng Zhang

Character raises $93m for eye drugs, plus other financings

Recent financings in the biotech space include rounds for Character Bio, Tempero, Epicrispr, Hillstar Bio, and Ampersand Biomedicines.

News

CARGO offloads staff after abandoning lead CAR-T

Less than 18 months after its IPO, CAR-T developer CARGO has abandoned its development efforts and slashed around 90% of its staff.

News

Roche taps Oxford BioTherapeutics for cancer drug discovery

Oxford BioTherapeutics has lined up another big pharma partner for its drug discovery platform, signing a $1bn deal with oncology giant Roche.

News

Sofinnova closes new fund and backs a trio of new biotechs

Sofinnova Partners has raised €165m for its new biotech fund and backed three startups working on Alzheimer's, fibrotic diseases, and cell therapies.

News

AstraZeneca buys cell therapy biotech for up to $1bn

AstraZeneca plans to acquire Belgian in vivo cell therapy biotech EsoBiotec and has signed a pair of licensing deals with drug delivery firm Alteogen.

J&J throws the gauntlet down to AZ with new survival data

Character raises $93m for eye drugs, plus other financings

CARGO offloads staff after abandoning lead CAR-T

Roche taps Oxford BioTherapeutics for cancer drug discovery

Sofinnova closes new fund and backs a trio of new biotechs

AstraZeneca buys cell therapy biotech for up to $1bn

ESC26: Isomab safety evidence on blood vessel growth for CAD

Discover a new era of healthcare panel engagement: Grounded ...

News

Editor's Picks